Workflow
Teladoc(TDOC)
icon
Search documents
Teladoc Health gaps down to support level after weak guidance
MarketBeat· 2024-02-21 19:57
Key PointsTeladoc Health stock is down sharply after weak 2024 guidance. The company is finding it harder to capture market share as virtual care is now a mainstream option.  Institutions may not be giving up on TDOC stock, but it may be a better trade than an investment.  5 stocks we like better than Teladoc HealthOne of 2021's favorite meme stocks is falling on hard times. Teladoc Health Inc. NYSE: TDOC stock is down more than 22% in early morning trading after the company delivered a poor outlook for 202 ...
Teladoc Health (TDOC) Q4 Loss Narrows on Lower Expenses
Zacks Investment Research· 2024-02-21 18:30
Teladoc Health, Inc. (TDOC) incurred a fourth-quarter 2023 adjusted loss of 17 cents per share, narrower than the Zacks Consensus Estimate of a loss of 22 cents per share and the year-ago quarter’s figure of a loss of $23.49 per share. The figure also came narrower than the management’s estimated range of a loss of 33-23 cents per share.Operating revenues improved 4% year over year to $660.5 million (within management’s expected range of $658-$683 million). The top line missed the consensus mark by 1.5%.The ...
Where Did Teladoc Stock Go Wrong?
The Motley Fool· 2024-02-21 16:55
It was another quarter, another disappointment for Teladoc Health (TDOC -24.62%) this week. Shares of the telehealth services provider plummeted sharply at the open on Wednesday after the company posted weaker-than-expected financial results.The report wasn't pretty, and its guidance was also underwhelming from a top-line growth perspective. Teladoc was a market darling when it hit the market as the country's first and largest telehealth platform nine years ago at $19 a share. It became a broken IPO on Wedn ...
Down 93%, Is Teladoc Stock a Buy?
The Motley Fool· 2024-02-21 14:21
Fool.com contributor Parkev Tatevosian determines if Teladoc (TDOC -2.57%) stock is a buy after it plunged 93% in the stock market. *Stock prices used were the afternoon prices of Feb. 18, 2024. The video was published on Feb. 20, 2024. ...
Why Is Teladoc Health (TDOC) Stock Down 21% Today?
InvestorPlace· 2024-02-21 13:41
Teladoc Health (NYSE:TDOC) stock is dropping on Wednesday after the virtual healthcare services company released its earnings report for the fourth quarter of 2023.The reason for this drop is Teladoc Health reporting revenue of $660.53 million in its earnings report. That’s below the $671.09 million that Wall Street was expecting for the quarter. Even if it’s a 4% increase year-over-year from $637.71 million.The company’s diluted earnings per share for the quarter came in at -17 cents. That’s better than th ...
Teladoc(TDOC) - 2023 Q4 - Earnings Call Transcript
2024-02-21 01:39
Financial Data and Key Metrics - Consolidated revenue for Q4 2023 grew 4% year-over-year to $661 million, with adjusted EBITDA increasing 22% to $114 million, representing a margin of 17.3% [35][41] - Full-year 2023 revenue was $2.6 billion, up 8% year-over-year, with adjusted EBITDA growing 33% to $328 million and margins expanding 240 basis points to 12.6% [73] - Free cash flow for Q4 2023 was $93.6 million, compared to $11.7 million in Q4 2022, with full-year free cash flow reaching $193.7 million, up from $16.5 million in 2022 [42] - The company ended 2023 with over $1.1 billion in cash and cash equivalents [42] Business Line Performance Integrated Care Segment - Q4 2023 revenue grew 8% year-over-year to $384 million, with segment margins expanding 230 basis points to 14.6% [35][74] - Full-year 2023 revenue for the segment increased 7% to $1.5 billion, driven by chronic care revenue growth [74] - Chronic care enrollment grew by 36,000 in Q4, bringing full-year net enrollment growth to 139,000, with total enrollment reaching 1.16 million, up 14% year-over-year [43] - Approximately 16% of the general medical client base has access to chronic care products, up from 12% two years ago [31][89] BetterHelp Segment - Q4 2023 revenue was $276 million, flat year-over-year, with adjusted EBITDA growing 11% to $58 million and margins expanding 210 basis points to 21.2% [30][44] - Full-year 2023 revenue for BetterHelp was $1.1 billion, up 11% year-over-year, with adjusted EBITDA growing 19% to $136 million and margins expanding to 12% [44] - Marketing yields for BetterHelp were below expectations in the second half of 2023, particularly in social media channels, impacting growth [30][96] Market Performance - The U.S. virtual care business, which accounts for roughly half of the Integrated Care segment, is expected to grow in the low single digits due to market penetration [36] - International B2B business, particularly in Canada, is a steady contributor to revenue growth, with expanded presence expected to drive visibility into 2024 growth [37] - BetterHelp's international revenue accounted for 15% of fiscal 2023 revenue, with efforts underway to expand further into non-English-speaking markets [38] Strategic Direction and Industry Competition - The company is targeting 50 to 100 basis points of annual margin expansion over the next three years, with a goal of reaching at least $425 million in adjusted EBITDA by 2025 [29][53] - Productivity initiatives, including automation and organizational realignment, are expected to deliver $85 million in annual run-rate savings by the end of 2024 [40] - The company is focusing on cross-selling chronic care products to its existing client base, with 75% of bookings coming from upsells or expansions with existing clients [34][89] - Investments in technology, including AI and machine learning, are seen as key competitive advantages to drive engagement and multi-product utilization [39] Management Commentary on Operating Environment and Future Outlook - Management expects mid-single-digit annual revenue growth for the Integrated Care segment and low single-digit growth for BetterHelp over the next three years [37][53] - The company anticipates continued pressure on customer acquisition costs in the first half of 2024, with easier comps in the second half [2][86] - BetterHelp's growth is gated by the ability to deploy capital efficiently at acceptable rates of return, with a focus on profitable growth [69][113] Other Key Information - The company identified a technical issue in mapping new client populations, delaying B2B consumer engagement efforts and impacting 2024 revenue by approximately $20 million [78][84] - Share buybacks are being considered to offset potential dilution from employee stock grants, with $1.1 billion in cash providing flexibility for strategic opportunities [19][80] Q&A Summary Question: Capital Deployment and Debt Management [6] - The company has $550 million in convertible debt due in June 2025 and $1 billion due in 2027, with plans to use cash to pay down debt and consider share buybacks [16][118] Question: BetterHelp Marketing Yields [17] - Marketing yields for BetterHelp remain depressed due to increased competition in the ad space, with no single competitor driving up rates [18][96] Question: Portfolio Assessment [23] - The company is conducting a portfolio assessment to evaluate profitability and growth outlook across customer segments, geographies, and products, with no significant changes expected in the near term [105] Question: Chronic Care Growth and Bundling [57] - Chronic care growth is expected to be mid to high single digits, with bundled programs contributing to higher revenue per client but lower revenue per member [108] Question: Cost Savings Program [93] - The $35 million in cost savings for 2024 is expected to benefit adjusted EBITDA, with most savings coming from the Integrated Care segment [114] Question: Delayed Enrollment Impact [115] - A technical issue in mapping new client populations delayed consumer engagement marketing by three to four weeks, impacting chronic care program enrollment [115]
Teladoc (TDOC) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
Zacks Investment Research· 2024-02-21 01:01
Teladoc (TDOC) reported $660.53 million in revenue for the quarter ended December 2023, representing a year-over-year increase of 3.6%. EPS of -$0.17 for the same period compares to -$0.23 a year ago.The reported revenue represents a surprise of -1.53% over the Zacks Consensus Estimate of $670.77 million. With the consensus EPS estimate being -$0.22, the EPS surprise was +22.73%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall S ...
Teladoc (TDOC) Reports Q4 Loss, Misses Revenue Estimates
Zacks Investment Research· 2024-02-20 23:26
Teladoc (TDOC) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to loss of $0.23 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 22.73%. A quarter ago, it was expected that this telehealth services provider would post a loss of $0.37 per share when it actually produced a loss of $0.35, delivering a surprise of 5.41%.Over the last four quarters, the company ...
Teladoc's stock sinks on downbeat forecast
Market Watch· 2024-02-20 21:38
Shares of telehealth-technology provider Teladoc Health Inc. TDOC sank after hours on Tuesday following a largely downbeat forecast for the first quarter and full year. The company, known for its BetterHelp therapy app, said it expected first-quarter sales of $630 million to $645 million, below FactSet forecasts of $673 million. It said it expected to lose 45 cents a share to 55 cents a share during that period, worse than analyst expectations for a 41-cent per-share loss. For the full year, Teladoc said i ...
Is Teladoc Stock a Buy Now?
The Motley Fool· 2024-02-20 14:53
The so-called "pandemic stocks" are a group of companies that performed well during the early days of the coronavirus outbreak since, for whatever reason, their businesses were equipped to thrive in these highly unusual conditions. Telehealth specialist Teladoc Health (TDOC -3.23%) was one of them. The company provided a convenient way for patients to get medical care without leaving their homes.However, like many other pandemic stocks, Teladoc has been on a southbound spiral since early 2021. The company's ...